Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

OXACILLIN SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Oxacillin Sodium, and what generic alternatives are available?

Oxacillin Sodium is a drug marketed by Elkins Sinn, Ani Pharms Inc, Sandoz, Aurobindo Pharma Ltd, Sagent Pharms, Apothecon, Hospira Inc, Teva, Watson Labs Inc, Mylan Labs Ltd, and Istituto Bio Ita Spa. and is included in seventeen NDAs.

The generic ingredient in OXACILLIN SODIUM is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.

Summary for Tradename: OXACILLIN SODIUM

Patents:0
Applicants:11
NDAs:17
Suppliers / Packagers: see list5
Bulk Api Vendors: see list65
Clinical Trials: see list923
Patent Applications: see list4,918
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXACILLIN SODIUM at DailyMed

Pharmacology for Tradename: OXACILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Istituto Bio Ita Spa
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION062798-001Dec 11, 1995DISCNNoNo► Subscribe► Subscribe
Sandoz
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION061490-004Approved Prior to Jan 1, 1982APRXNoYes► Subscribe► Subscribe
Istituto Bio Ita Spa
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION062798-005Dec 11, 1995DISCNNoNo► Subscribe► Subscribe
Watson Labs Inc
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION062984-001Sep 29, 1988DISCNNoNo► Subscribe► Subscribe
Sandoz
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION061490-006May 9, 1991APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot